Xinyuan Lei

Has grant

Research Assistant/Teaching Assistant

Stony Brook University
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Xinyuan Lei is a Research Assistant and Teaching Assistant at Stony Brook University in the United States. Their research focuses on tumor biology, immune escape mechanisms in solid tumors, and the role of non-coding RNAs in cancer metastasis and treatment response. Recent publications include studies on STAT3 in mutant KRAS contexts, retinoic acid signaling in immune cell differentiation, and the effects of histone deacetylase inhibitors on CAR T cell activity in solid tumors.

Recent Grants

Grant: Close

Mitochondrial Dynamin-related Protein 1 Regulates the Expression of MHC-I and Immunogenicity of TSCC (81872194)

Open Date: 2018-01-01

Close Date: 2023-06-01

Grant: Close

Mitochondrial Dynamin-related Protein 1 Regulates Mitochondrial Fission and Cisplatin Sensitivity of TSCC (2017A030313501)

Open Date: 2017-12-01

Close Date: 2021-03-01

Articles (6)

Year:

2025

CD8 tissue-resident memory T (TRM) cells provide frontline protection at barrier tissues; however, mechanisms regulating TRM cell development are not completely understood. Priming dictates the migration of effector T cells to the tissue, while factors in the tissue induce in situ TRM cell differentiation. Whether priming also regulates in situ TRM cell differentiation uncoupled from migration is unclear. Here, we demonstrate that T cell priming in the mesenteric lymph nodes (MLN) regulates CD103+ TRM cell differentiation in the intestine. In contrast, T cells primed in the spleen were impaired in the ability to differentiate into CD103+ TRM cells after entry into the intestine. MLN priming initiated a CD103+ TRM cell gene signature and licensed rapid CD103+ TRM cell differentiation in response to factors in the intestine. Licensing was regulated by retinoic acid signaling and primarily driven by factors other than CCR9 expression and CCR9-mediated gut homing. Thus, the MLN is specialized to promote intestinal CD103+ CD8 TRM cell development by licensing in situ differentiation.

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Ananthan Sadagopan

Harvard University

UNITED STATES
View details

Brian S. Sheridan

-

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.